The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter
- PMID: 9460519
- DOI: 10.1007/BF03165295
The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter
Abstract
The aim of this study is to investigate the value of Tc-99m tetrofosmin (Tc-99m-TF) in conjunction with conventional Tc-99m-pertechnetate (Tc-99m-P) scintigraphy in the differentiation of malignant nodules from benign thyroid nodules. Forty-two patients [(32 females, 10 males; mean age 41 +/- 13 years; twenty-two multinodular goiter (MNG) patients with 58 nodules and 20 solitary thyroid nodules (STN)] were included in the study. Thyroid scintigraphy with Tc-99m-P and Tc-99m-TF, thyroid ultrasonography and fine needle aspiration cytology (FNAC) were performed. After i.v. injection of 370-550 MBq Tc-99m-TF, images were obtained at 15 minutes and evaluated semiquantitatively by using a five point (0-4) scoring system. Four patients with a hypoactive STN, and 1 patient with a hypoactive MNG was found to have thyroid malignancy by histopathological examination; 2 of these patients had false negative benign FNAC results. The tetrofosmin uptake score (TUS) was 2-3-3-3 and 3 in these 5 malignant nodules. Five hyperactive (hot or warm) STN with benign FNAC had a TUS of 2-3-3-3-3. All hypoactive (cold) MNG nodules with benign FNAC (n = 21) had TUS < or = 2. Our preliminary results suggest that follicular adenomas and thyroid cancers have higher tetrofosmin uptake than benign colloidal goiter nodules. Mitochondrial sequestration of tetrofosmin in benign or malignant follicular cells that proliferate more rapidly than normal follicular cells and/or hypervascularity may be responsible for this. The use of Tc-99m-TF in conjunction with Tc-99m-P thyroid scintigraphy will be helpful in the evaluation of patients with nodular goiter (NG). In patients with a STN, a hypoactive nodule with a high TUS has a higher probability of malignancy; whereas a hyperactive nodule with a high TUS is a follicular adenoma. In patients with MNG, a hypoactive nodule with a high TUS may be suggestive of malignancy despite a benign FNAC result. We think that further studies with Tc-99m-TF are required to confirm these results.
Similar articles
-
The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the differential diagnosis of cold thyroid nodules.Eur J Nucl Med. 1999 Aug;26(8):798-803. doi: 10.1007/s002590050451. Eur J Nucl Med. 1999. PMID: 10436190
-
Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.Eur J Nucl Med. 1996 Dec;23(12):1568-74. doi: 10.1007/BF01249618. Eur J Nucl Med. 1996. PMID: 8929309
-
Efficacy of dual use of Tc-99m-pertechnetate and Tc-99m-tetrofosmin scintigraphy for the assessment of thyroid nodules.J Med Imaging Radiat Oncol. 2020 Apr;64(2):189-196. doi: 10.1111/1754-9485.13006. Epub 2020 Feb 26. J Med Imaging Radiat Oncol. 2020. PMID: 32103595
-
[The use of imaging modalities in patient with thyroid nodule: ultrasonography and radionuclide scintigraphy with new tracers].Harefuah. 2001 May;140(5):421-4. Harefuah. 2001. PMID: 11419067 Review. Hebrew. No abstract available.
-
The role of F-18FDG PET in thyroid cancer.Acta Med Austriaca. 2000;27(2):38-41. Acta Med Austriaca. 2000. PMID: 10812462 Review.
Cited by
-
(99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index.J Neurooncol. 2008 Sep;89(2):225-30. doi: 10.1007/s11060-008-9611-8. Epub 2008 May 6. J Neurooncol. 2008. PMID: 18458817
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous